Glanzmann thrombasthenia (GT) is a rare inherited autosomal recessive bleeding disorder
of platelet function caused by a quantitative or qualitative defect of platelet membrane …

Glanzmann's thrombasthenia (GT) is a genetic platelet surface receptor disorder of GPIIb/IIIa
(ITG αIIbβ3), either qualitative or quantitative, which results in faulty platelet aggregation and …

Glanzmann's thrombasthenia (GT) is a rare congenital bleeding disorder caused by
deficiency or dysfunction of platelet surface glycoprotein (GP) IIb/IIIa receptor. Platelet …

Glanzmann's thrombasthenia (GT) is a congenital qualitative platelet disorders due to the
deficiency or defect of platelet membrane GPIIb/IIIa (integrin αIIbβ3). The standard treatment …

Glanzmann thrombasthenia (GT) is an autosomal recessive disorder of platelet aggregation
caused by quantitative or qualitative defects in integrins αIIb and β3. These integrins are …

Glanzmann's thrombasthenia (GT) is a rare bleeding disorder characterized by a
quantitative or qualitative defect of glycoprotein IIb/IIIa on the platelet membrane. Managing …

Glanzmann thrombasthenia (GT) is a rare autosomal recessive disorder characterized by
qualitative or quantitative abnormalities of the platelet membrane glycoprotein (GP) IIb/IIIa …

Glanzmann's Thrombasthenia (GT) is a rare autosomal recessive bleeding disorder,
characterized by a quantitative or qualitative defect of platelet surface α IIb-β 3 integrin …

Glanzmann thrombasthenia (GT) is a rare autosomal recessive bleeding syndrome affecting
the megakaryocyte lineage and characterized by lack of platelet aggregation. The molecular …

Platelet transfusion is the standard treatment to control or prevent bleeding in patients with
Glanzmann's thrombasthenia (GT), but platelets are often unavailable. Recombinant …